The application axis of Central Extraction System market taxonomy reflects end‑use demand patterns and regulatory environments. Pharmaceutical extraction, which targets active pharmaceutical ingredients and intermediates, commands the largest share at roughly 35 % due to stringent purity standards and high unit values; its growth is propelled by biologics and personalized medicine trends. Food & beverage extraction, covering flavors, nutraceuticals, and functional ingredients, accounts for about 30 % of sales, driven by consumer demand for clean‑label products and plant‑based proteins. Chemical processing applications, including polymer additives and specialty chemicals, represent 20 % of the market, where solvent recovery efficiency and process scalability are critical. Environmental uses, such as wastewater remediation and soil decontamination, hold a 10 % slice, benefiting from increasing sustainability mandates and government incentives. The remaining 5 % comprises niche sectors like cosmetics and petrochemicals, where bespoke extraction configurations are required. This application‑focused Central Extraction System segmentation determines capital allocation, R&D emphasis, and regional market penetration strategies.